Targeting mitochondrial translation as a novel therapeutic strategy for AML
Targeting mitochondrial translation as a novel therapeutic strategy for AML
批准号:
289699
负责人:
Schimmer Aaron D
金额:
$59.74万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-09-01 至 2018-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
AML (acute myeloid leukemia) is a disease with a poor outcome for which new therapeutic agents are needed. To identify new treatment strategies for AML, we screened a large chemical library of old drugs and identified tigecycline, a drug used for treatme
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The IL23 Receptor (IL23R) regulates mitotic spindle formation and is a novel therapeutic target for AML
-
批准号:483377
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2023
-
负责人:Schimmer Aaron D
-
依托单位:
Improved treatments of Acute Myeloid Leukaemias by Personalized Medicine
-
批准号:387780
-
项目类别:Operating Grants
-
资助金额:$32.78万
-
财政年份:2018
-
负责人:Schimmer Aaron D
-
依托单位:
Developing new therapeutic strategies for AML (Acute Myeloid Leukemia)
-
批准号:354022
-
项目类别:Operating Grants
-
资助金额:$242.84万
-
财政年份:2016
-
负责人:Schimmer Aaron D
-
依托单位:
Targeting mitochondrial protein folding in the inter-membrane space as a novel therapeutic strategy for AML
-
批准号:354325
-
项目类别:Operating Grants
-
资助金额:$52.94万
-
财政年份:2016
-
负责人:Schimmer Aaron D
-
依托单位:
Targeting the mitochondrial proteasome, ClpP, in AML
-
批准号:303444
-
项目类别:Operating Grants
-
资助金额:$51.54万
-
财政年份:2014
-
负责人:Schimmer Aaron D
-
依托单位:
Inhibiting oncogenic kinases to target metabolism in AML
-
批准号:265305
-
项目类别:Operating Grants
-
资助金额:$52.04万
-
财政年份:2012
-
负责人:Schimmer Aaron D
-
依托单位:
Repositioning tigecycline for the treatment of leukemia
-
批准号:212701
-
项目类别:Operating Grants
-
资助金额:$11.42万
-
财政年份:2010
-
负责人:Schimmer Aaron D
-
依托单位:
国内基金
海外基金
一碳代谢(One carbon metabolism)介导上调的 PD1/PDL1 驱动
肿瘤免疫逃逸
-
批准号:2024JJ9491
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:彭罗根
-
依托单位: